On Invalid Date, Cryo Cell International (NYSEMKT: CCEL) reported Q4 2023 earnings per share (EPS) of -$1.34, up 1,440% year over year. Total Cryo Cell International earnings for the quarter were -$11.19 million. In the same quarter last year, Cryo Cell International's earnings per share (EPS) was $0.10.
As of Q1 2024, Cryo Cell International's earnings has grown year over year. Cryo Cell International's earnings in the past year totalled -$9.52 million.
What is CCEL's earnings date?
Cryo Cell International's earnings date is Invalid Date. Add CCEL to your watchlist to be reminded of CCEL's next earnings announcement.
What was CCEL's revenue last quarter?
On Invalid Date, Cryo Cell International (NYSEMKT: CCEL) reported Q4 2023 revenue of $7.88 million up 1.45% year over year. In the same quarter last year, Cryo Cell International's revenue was $7.76 million.
What was CCEL's revenue growth in the past year?
As of Q1 2024, Cryo Cell International's revenue has grown 3.32% year over year. This is 5.22 percentage points lower than the US Medical Care Facilities industry revenue growth rate of 8.54%. Cryo Cell International's revenue in the past year totalled $31.34 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.